Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/26/1998 | CA2285580A1 Gastroretentive controlled release microspheres for improved drug delivery |
11/25/1998 | EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance |
11/25/1998 | EP0879601A2 Ophthalmic drug delivery system |
11/25/1998 | EP0879597A1 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
11/25/1998 | EP0879589A1 Nanoemulsions based on non-ionic amphiphilic lipids aminated silicones and their use |
11/25/1998 | EP0879258A1 Copolymers with polyester polycarbonate blocks containing poly(caprolactone) segments, and use thereof for the preparation of biodegradable matrices |
11/25/1998 | EP0879249A1 Modified inulin |
11/25/1998 | EP0879236A1 Derivatives of camptothecin for use in treating cancer |
11/25/1998 | EP0879063A1 Preparation and use of magnetically susceptible polymer particles |
11/25/1998 | EP0879062A2 Nucleic acid delivery vehicle |
11/25/1998 | EP0879057A1 Granules from triazines |
11/25/1998 | EP0879052A1 Preparations stimulating nail growth |
11/25/1998 | EP0879051A1 Rate-controlled transdermal administration of risperidone |
11/25/1998 | EP0879050A1 Captopril tablets |
11/25/1998 | EP0879049A1 Process to prepare soluble delivery systems using volatile salts |
11/25/1998 | EP0879048A1 Solid formulations containing trehalose |
11/25/1998 | EP0879035A1 Bismuth-containing compounds in topical dosage forms |
11/25/1998 | EP0815846B1 Ultrafine oil-in-water emulsion containing a crosslinked at least 90% neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid and method of preparation |
11/25/1998 | EP0815844B1 Topical surfactant-free oil-in-water emulsion containing a crosslinked neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid |
11/25/1998 | EP0810868A4 Use of piperine as a bioavailability enhancer |
11/25/1998 | EP0804175B1 Process and device for producing a flat dry-administration form with a preparation containing active medical agents |
11/25/1998 | EP0717614B1 Effervescent granulated material and method for its preparation |
11/25/1998 | EP0716595B1 Dispenser containing hydrophobic agent |
11/25/1998 | EP0700283B1 Liquid antacid compositions |
11/25/1998 | EP0699091B1 Method and device for the production of a transdermal therapeutic system |
11/25/1998 | EP0697887B1 Stable liquid compositions of gamma interferon |
11/25/1998 | EP0696920B1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug |
11/25/1998 | EP0690728B1 Preservative system for contact lens solutions |
11/25/1998 | EP0689458B1 Active-substance patch for releasing estradiol to the skin |
11/25/1998 | EP0670717B1 Supported liquid membrane delivery devices |
11/25/1998 | EP0654994B1 Use of cineol or menthol for the treament of asthma |
11/25/1998 | EP0639202B1 Stable polypeptide composition |
11/25/1998 | EP0621773B1 Formulation and use of carotenoids in treatment of cancer |
11/25/1998 | EP0553113B1 Adhesion receptors for pathogenic or opportunistic microorganisms |
11/25/1998 | EP0526566B1 Treatment of erectile dysfunction |
11/25/1998 | EP0498824B2 Process of preparing a water dispersible hydrophobic or aerophilic solid |
11/25/1998 | CN1200038A Method for the production of tablets by pressing and tablets produced by the method |
11/25/1998 | CN1200036A Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
11/25/1998 | CN1200034A Method of producing medicaments in solid form |
11/25/1998 | CN1200033A Method of producing multi-layer medicaments in solid form for oral or rectal administration |
11/25/1998 | CN1200032A Process to manufacture implants containing bioactive peptides |
11/25/1998 | CN1200017A Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
11/25/1998 | CN1199744A Block copolymers and their use as polymeric surfactants |
11/25/1998 | CN1199637A Sebidan pellet |
11/25/1998 | CN1199635A Cough and asthma curing plaster stuck to acupoint |
11/25/1998 | CN1199634A Medicine for hernia and its preparation process and medicated deltoid belt |
11/25/1998 | CN1199626A Baoling liquid for health care and its preparation process |
11/25/1998 | CN1199613A Preparation having increased in vivo tolerability |
11/25/1998 | CN1199612A Preparation of new-type antimalarial drug artemisin methyl ether capsule |
11/25/1998 | CN1199611A Calcium replenishing chewing tablet |
11/25/1998 | CN1040840C Antibiotic embedding agent and preparing method |
11/24/1998 | US5840943 Esterifying a polyhydroxystearic acid having a degree of self-condensation of from 2 to 20 with polyglycerol component; emulsifiers |
11/24/1998 | US5840878 Tablets of glass and/or zirconium/silicate beads in dissolvable binder (e.g.trehalose); lysis of cell walls and separation of nucleic acids from other cellular components |
11/24/1998 | US5840845 Senescent cell derived inhibitors of DNA synthesis |
11/24/1998 | US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product |
11/24/1998 | US5840769 Comprising powdered cellulose, soluble polyvinylpyrrolidone, crosslinked insoluble polyvinylpyrrolidone in specified amounts |
11/24/1998 | US5840768 MCC: alginate pharmaceutical suspensions |
11/24/1998 | US5840756 Pharmaceutical composition of L-DOPA ester |
11/24/1998 | US5840755 Method and composition for topical therapy of headaches |
11/24/1998 | US5840754 Dosage form comprising oxybutynin |
11/24/1998 | US5840744 Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
11/24/1998 | US5840714 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, pharmaceutical preparations containing said inclusion complexes and methods for using same |
11/24/1998 | US5840710 Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
11/24/1998 | US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component |
11/24/1998 | US5840701 Antiischemic agents and macomolecules |
11/24/1998 | US5840685 Intravaginal delivery of biologically active polypeptides |
11/24/1998 | US5840674 Delivering active materials to mammalian cells |
11/24/1998 | US5840547 Bioemulsifiers |
11/24/1998 | US5840498 Antibiotic cryptdin peptides and methods of their use |
11/24/1998 | US5840341 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
11/24/1998 | US5840340 Oligopeptides with fragrance, cosmetics and dye |
11/24/1998 | US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate |
11/24/1998 | US5840336 Two-phase matrix for sustained release drug delivery device |
11/24/1998 | US5840335 System for the controlled release of active agents and a process for its preparation |
11/24/1998 | US5840334 Glycerine-free |
11/24/1998 | US5840333 Process for the preparation of oral compositions containing quinolones |
11/24/1998 | US5840332 Gastrointestinal drug delivery system |
11/24/1998 | US5840330 Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
11/24/1998 | US5840329 Groups of particles having distinct pattern of drug release based on combination of controlled release layers, swelling agents and coatings; controlled release layer of slightly crosslinked polyacrylic acid and water soluble polymer |
11/24/1998 | US5840328 Treatment using arachidonic acid metabolite and particulate formulations |
11/24/1998 | US5840327 Transdermal drug delivery device having enhanced adhesion |
11/24/1998 | US5840325 Osteogenic devices |
11/24/1998 | US5840324 Particulate composition for combating and preventing parasitic infestation of ruminants with controlled release in various environments of ruminant gastrointestinal system |
11/24/1998 | US5840319 Biological agent compositions |
11/24/1998 | US5840293 Topical composition comprising carrier with dispersed noncollapsible crosslinked polymeric beads having network of internal pores containing active substance and exterior surface charge which promotes adhesion to keratinic materials |
11/24/1998 | US5840283 Composition and method for treating diseased nails |
11/24/1998 | US5840279 Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
11/24/1998 | US5840278 Nasal spray having a mineral vitamin component, a mineral component and aloe vera |
11/24/1998 | US5840277 Treatment of chronic pulmonary inflammation |
11/24/1998 | US5840276 Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis |
11/24/1998 | US5840275 Ultrasonic contrast agent with polymeric gas or air filled microballoons |
11/24/1998 | US5840252 Basifying liquid product, adding carbon dioxide or carbon dioxide-forming compound to solution, storing in gas permeable container, allowing ph to increase with release of carbon dioxide; stable dialysis solutions |
11/24/1998 | US5840074 Method and apparatus for delivering first agent followed by second agent |
11/24/1998 | US5840054 Method for obstructing lacrimal canaliculi with infusable solution or dispersion |
11/24/1998 | CA2093321C Transdermal device |
11/24/1998 | CA2082944C Pharmaceutical compositions |
11/24/1998 | CA2007181C Sustained release pharmaceutical composition |
11/19/1998 | WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
11/19/1998 | WO1998051712A1 Chitin beads, chitosan beads, processes for producing these beads, carriers made of these beads and processes for producing microsprodidian spores |
11/19/1998 | WO1998051711A1 Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore |